At the CTGCT, we recognize patients as essential partners in our mission to develop and implement innovative gene and cell therapies. We are committed to actively involving patients, carers, and families throughout our research journey. This includes regular updates on our progress through various channels such as social media, webinars, and newsletters, ensuring you stay informed about the latest advancements in rare diseases and cancer immunotherapy. We also engage patient representatives in our project planning to ensure our research aligns with your needs and priorities.
We believe in the power of shared experiences and the importance of trust. That’s why we collaborate closely with patient organizations and share real-life case studies of individuals treated with Advanced Therapy Medicinal Products (ATMPs). This approach not only helps to demystify these novel therapies but also demonstrates their potential impact on people’s lives. By fostering open communication between patients, researchers, and clinicians, we aim to create a supportive environment where you can make informed decisions about your treatment options. Your voice and experiences are invaluable in shaping the future of gene and cell therapies, and we are dedicated to amplifying your perspective in every aspect of our work.